A critique of the double-blind clinical trial part 2

Alternative Therapies in Health and Medicine

Volumn 2, Issue 2, 1996, Pages 59-64

  Kiene, Helmut ^a,b  

^a Institut fur angewandte Erkenntnistheorie und medizinische Methodologie e V   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; HUMAN; RESEARCH; REVIEW;

CLINICAL TRIALS; DOUBLE-BLIND METHOD; HUMANS; RESEARCH;

EID: 0030096001     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Affleck C, Eaton M, Mansfield E. The action of a medication and the physician's expectation. Nebr State Med J. 1966;51(8):331-334.
2. Wied GI. Über die Bedeutung der Suggestion in der Therapie klimakterischer Ausfallerscheinungen. Ärztl Wschr. 1953;8:623-625.
3. Downing RW, Rickels K. Prediction of response to chlordiazepoxid and placebo in anxious outpatients: an attempt at replication. Pharmakopsychol. 1978;11:207-219.
4. Uhlenhuth EH, Canter A, Neustadt JO, Payson HE. The symptomatic relief of anxiety with meprobamate, phenobarbital and placebo. Am J Psychiatry. 1959;115:905-910.
5. Fisher S, Rickels K, Cole J, Uhlenhuth EH. Drug-set interaction: the effect of expectations on drug response in outpatients. In: Bradley PB, Fluegel F, Hoch H, eds. Coll Internat Neuro-Psychopharmacologicum, Proc 3rd Meeting. Munich, Germany: Elivisier; 1962.
6. Uhlenhuth EH, Rickels K, Fisher S, Park LC, Lipman RS, Mock J. Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy. Psychopharmacologia (Berl). 1966;9:392-418.
7. Rickels K, Lipman R, Raab E. Previous medication, duration of illness and placebo response. J Nerv Ment Dis. 1966;142:548-554.
8. Rickels K, Baumm C, Raab E, Taylor W, Moore E. A psychopharmacological evaluation of chlordiazepoxide. LA-1 and placebo carried out with neurotic medical clinic patients. Med Times. 1965;93:238-245.
9. Glick BS. Placebo as prognosticator. Dis Nerv Syst. 1967;2:737-743.
10. Hankoff LD, Freedman N, Engelhardt DM. The prognostic value of placebo response. Am J Psychiatry. 1958;115:549-550.
11. Hankotf LD, Engelhardt DM, Freedman N. Placebo response on schizophrenic outpatients. Arch Gen Psychiatry. 1960;2:43/33-52/42.
12. Janke W. Untersuchungen der Placeboreaktivität: Vorhersagbarkeit der Reaktion gesunder Personen auf Placebo mit Stimulans-Instruktionen. In: Hippius H (Hrsg). Das Placebo-Problem. Stuttgart, Germany and New York, NY: Gustav Fischer Verlag; 1986:151-173.
13. Joyce CRB. Consistent differences in individual reactions to drugs and dummies. Br J Pharmacol Chemotherapy. 1959;14:512-521.
14. Linton HB, Langs RJ. Subjective reactions to lysergic acid diethylamides: measured by a questionnaire. Arch Gen Psychiatry. 1962;6:352.
15. Shapiro AK. Study of the placebo effect with a self-administered placebo test. Compr Psychiatry. 1973;14:535-548.
16. Jellinek EM. Clinical tests on comparative effectiveness of analgetic drugs. Biometrics. 1946;2:87-91.
17. Beecher HK, Keats AS, Mosteller F, Lasagna L. The effectiveness of oral analgesics (morphine, codeine, acetylsalicylic acid) and the problem of placebo "reactors" and "non-reactors." J Pharmacol Exp Ther. 1953;109:393-400.
18. Janicki AG, Orzechowska-Juzuenko K, Swiderska-Blonska T. The methodological and clinical aspects of the placebo effect in angina pectoris. Cor Vasa. 1988;30:35-42.
19. Lasagna L, Mosteller F, Felsinger JM, Beecher HK. A study on the placebo response. Am J Med. 1954;16:770-779.
20. Reimherr FW, Ward MF, Byerley WF. The introductory placebo washout: a retrospective evaluation. Psychiatry Res. 1989;30:191-199.
21. Kohnen R, Lienert GA. Placebo-Effekte - Ein Phänomen der Untersuchungsmethode? In: Hippius H (Hrsg). Das Placebo-Problem. Stuttgart. Germany and New York, NY: Gustav Fischer Verlag; 1986:49-60.
22. Schachter S, Singer JE. Cognitive, social, and physiological determinants of emotional state. Psychol Rev. 1962;69:379-399.
23. Schachter S. The interaction of cognitive and physiological determinants of emotional state. In: Berkowitz L, ed. Advances in Experimental Social Psychology. Vol 1. New York, NY: Academic Press; 1964.
24. Dinnerstein A, Lowenthal M, Blitz B. The interaction of drugs with placebos in the control of pain and anxiety. Perspect Biol Med. 1966;66:103-117.
25. Dinnerstein A. Marijuana and perceptual style: a theoretical note. Percept Mot Skills. 1968;26:1016-1018.
26. Dinnerstein A, Halm J. Modification of placebo effects by means of drugs: effects of aspirin and placebos on self-rated moods. J Abnorm Psychol 1970;75:308-314.
27. Penick S, Fisher S. Drug-set interaction: psychological and physiological effects of epinephrine under differential expectations. Psychosom Med. 1965;27:177-182.
28. Penick S, Hinkle L The effect of expectation on response to phenmetrazine. Psychosom Med. 1964;26:369-373.
29. Storms M, Nisbett R. Insomnia and the attribution process. J Pers Soc Psychol. 1970;16:319-328.
30. Kellog R, Baron RS. Attribution theory, insomnia and the reverse placebo effect: a reversal of Storms and Nisbett's findings. J Pers Soc Psychol. 1975;32:231-236.
31. Bootzin RR, Herman CP, Nicassio P. The power of suggestion: another examination of misattribution and insomnia. J Pers Soc Pychol. 1976;34:673-679.
32. Lowery C, Denney D, Storms M. Insomnia: a comparison of the effect of pill attributions and nonpejorative self-attributions. Cognit Ther Res. 1979;3:161-164.
33. Ross M, Olson JM. An expectancy-attribution model of the effects of placebos. Psychol Rev. 1981;8:408-437.
34. Kirsch I, Weixel LJ. Double-blind versus deceptive administration of a placebo. Behav Neurosci. 1988;102:319-323.
35. Hornung J. Zur Problematik der Doppelblindstudien. Therapeutikon. 1989;3:696-701.
36. Pocock, SJ. Clinical Trials: A Practical Approach. Chicester, England and New York, NY: John Wiley and Sons; 1983:50.